Seeing Is Believing

Currently out of the existing stock ratings of Michael Jungling, 13 are a BUY (61.9%), 7 are a HOLD (33.33%), 1 are a SELL (4.76%).
Analyst Michael Jungling, currently employed at BARCLAYS, carries an average stock price target met ratio of 23.33% that have a potential upside of 9.82% achieved within 139 days.
Michael Jungling’s has documented 42 price targets and ratings displayed on 6 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on FMS, Fresenius Medical Care at 24-Sep-2021.
Analyst best performing recommendations are on SNN (SMITH & NEPHEW SNATS).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 4/22/2020. The price target of $48.84 was fulfilled within 261 days with a profit of $12.17 (33.19%) receiving and performance score of 1.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Dec-2025
$39
14 days ago
(08-Sep-2026)
0/1 (0%)
$6 (18.18%)
Hold Since 17-Mar-2025
$30
$-0.04 (-0.13%)
$35
4 months 11 days ago
(11-May-2026)
5/6 (83.33%)
$0.9 (3.09%)
16
Buy Since 29-Jan-2025
$37.5
$7.46 (24.83%)
11 months 8 days ago
(14-Oct-2025)
2/4 (50%)
$2.24 (6.35%)
762
Buy Since 12-Mar-2025
1 years 6 months 10 days ago
(12-Mar-2025)
0/5 (0%)
$-11.32 (-45.15%)
Buy Since 11-Apr-2023
$17.57
1 years 8 months 16 days ago
(06-Jan-2025)
0/6 (0%)
$-8.69 (-33.09%)
What Year was the first public recommendation made by Michael Jungling?